Novo Nordisk to boost rare disease portfolio with $1.1B acquisition

The latest stories trending on MedCity News.

Not rendering correctly? View this email as a web page here. TOP STORIES Novo Nordisk to buy sickle cell disease biotech Forma Therapeutics in $1.1B deal Novo Nordisk announced that it will buy Forma Therapeutics, a clinical-stage biotech focused on rare hematologic diseases, in an deal valued at $1.1 billion. The deal is the second billion-dollar sickle cell disease deal the pharmaceutical industry has seen in the last 30 days — Pfizer forked over $5.4 billion in August to buy Global Blood Therapeutics. Sponsored Content Practical set of actions to provide operational security and protect your data From Ventech Solutions and MedCity News Actions ranging from data theft to ransomware cost the healthcare industry over $9.2 million on average for every breach. Guidelines for making computing environments that house and utilize sensitive protected healthcare data more secure are highlighted in a new whitepaper by Ventech. The report highlights the importance of achieving measurable compliance with required and effective security practices and guidance to help manage healthcare data-related security risks and ensure businesses can securely focus their core activities in a cost-effective and value-focused way. An Intimate Boutique Event Showcasing the Best in Digital Health Technology From MedCity News We personally invite you to join us at Pegasus Park in Dallas on Wednesday, September 28 to partake in thought provoking panel discussions. Plus, this event offers an 6:1 ratio of attendees to investors for those seeking funding and a desire to network.   Don't miss this valuable opportunity to network and connect: The healthcare super-utilizer and the United States of healthcare By Jon Knight Thursday, September 1, 2022 5:17 PM The implementation of patient-centric, value-based, wrap-around services that empower provider organizations to care for the whole person is essential to lowering healthcare costs and improving the lives of the super-utilizer population. Read more » Medable rolls out new decentralized trial software for speedier vaccine development By Katie Adams Thursday, September 1, 2022 5:12 PM Medable recently launched a software solution to shorten the launch times for decentralized vaccine trials. The company says the software can reduce trial deployment timelines from more than 12 weeks on average to as short as five weeks. Read more » Hello Heart launches cholesterol management feature to improve heart health By Marissa Plescia Thursday, September 1, 2022 5:03 PM The new feature allows users to see their cholesterol trends over time. They can input their readings from clinics and labs in one place, schedule appointments and receive digital coaching to make improvements. Read more » CMS proposed rule would streamline Medicaid/CHIP enrollment and renewal process By Marissa Plescia Thursday, September 1, 2022 12:59 PM The proposed rule would limit renewals to once every 12 months, allow applicants 30 days to respond to information requests and require consistent renewal processes across states. Currently, the enrollment and renewal process is burdensome and deters many Americans from enrolling even when they're eligible, CMS said. Read more » Breaking down how cognitive behavioral therapy and internet-based cognitive behavioral therapy help treat mental health struggles By Jorge Palacios Thursday, September 1, 2022 9:00 AM More people are turning to health solutions like Cognitive Behavioral Therapy and Internet-based Cognitive Behavioral Therapy (iCBT) to help minimize the negative mental health impact many are currently facing. Read more » Guide to Pharmaceutical Contract Management Excellence Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape. Download this FREE eBook to learn more! MedCity News   611 Broadway    New York,  NY   10012   United States You received this email because you are subscribed to MedCity Daily Digest from MedCity News. Update your email preferences to choose the types of emails you receive.  Unsubscribe from all future emails